Hiroshi Mikitani Explains The Startup Story of Rakuten

Mickey Mikitani, chairman and CEO of Rakuten Medical, explains in an interview for the fortune magazine the personal story about how he decided to participate in the fight against Cancer by investing in the Biotech market.

Since then, Rakuten Medical has been developing new cancer therapies based on Photoimmunotherapy. This innovative technique combines key advantages of antibody-mediated targeting of the cancer cells with laser-activation of a biophysical mechanism that induces rapid cancer cell death. To explain this revolutionary approach they requested us to make an impactful and comprehensive video from us. Thanks to our scientific animation they could easily visualize and explain their technology and the mechanism of action of the candidate Asp 1929 .

Rakuten Medical aims to commercialize this therapy once it has conducted clinical trials of the therapy on its own and in combination with other medications.

Source : Fortune


BIO Europe

BIO-Europe offers powerful opportunities at one conference for you to network with the right partners and bring together hundreds of the world’s most innovative technologies.

BIO International Convention

The BIO International Convention (BIO) attracts over 16,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.


BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.000) and companies participating (+800). 34% of our delegates came from outside of Spain.


CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 45,000 visiting pharma professionals over three days.


Once again, the world’s biggest medical trade fair MEDICA and the leading international supplier trade fair COMPAMED, which take place in Düsseldorf, have provided a powerful stimulus for the international medical technology industry.